Clinical Trial Update: Diabetic Macular Edema Treated With Ozurdex (DMEO) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the dexamethasone intravitreal implant Ozurdex for diabetic macular edema has completed, with results posted in August 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Johns Hopkins University | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED | Results posted: 2016-08-01